The largest risk to our thesis is that banking continues to generate reliable cash flow and the company can consistently ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

Vertex Pharmaceuticals announced FDA approval for Alyftrek, which expands the company's CF franchise to address around 6,000 ...

We came across a bullish thesis on PagSeguro Digital Ltd. (NYSE:PAGS) on the Value Investing Subreddit Page by photon_lines.

Pony AI, a Chinese autonomous driving tech leader, debuted on Nasdaq in Nov. Goldman Sachs says it has the largest Level 4 fleet in China. Analyst Allen Chang gave a Buy rating and $19.60 price target ...

We came across a bullish thesis on GitLab Inc. (GTLB) on High Growth Investing’s Substack by Stefan Waldhauser. In this ...

NEW YORK, Dec. 16, 2024 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on FlexShopper, Inc. (NasdaqCM:FPAY). Click Here to view ...

We came across a bullish thesis on Oatly Group AB (OTLY) on wallstreetbets Subreddit Page by boolean__. In this article, we ...

Fast-forward to 2024, and its latest fund will now “leaven the bread” of that thesis, with a fresh $180 ... for sure, with IPOs next year. The real question is, what are we Europeans doing ...

Gift 5 articles to anyone you choose each month when you subscribe. Chemist Warehouse could have floated any year, in any IPO market conditions. It is that strong a business. Its founders chose to ...

Suraksha Diagnostics IPO: The medical consultancy services company has fixed the issue price at ₹420 to ₹441 apiece.(Photo: Courtesy company website) Suraksha Diagnostics IPO: The mainboard ...